CADL EPS Estimates
Candel Therapeutics, Inc.
$7.99
-$0.20(-2.44%)
39
Overall
60
Value
36
Tech
21
Quality
Market Cap
$626.69M
Volume
189.01K
52W Range
$4.35 - $14.00
Target Price
$21.75
CADL EPS estimates: the consensus estimate for Candel Therapeutics, Inc.'s current fiscal year is -$1.29 per share. Quarterly and next-year EPS forecasts, growth estimates and revenue projections follow.
CADL EPS Estimates
- EPS estimate, current quarter
- $-0.30
- EPS estimate, next quarter
- $-0.33
- EPS estimate, current year
- $-1.29
- EPS estimate, next year
- $-1.27
- EPS growth, 3-year
- -3.47%
| Fiscal year | EPS |
|---|---|
| 2025 | $-0.72 |
| 2024 | $-1.74 |
| 2023 | $-1.31 |
| 2022 | $-0.65 |
| 2021 | $-1.91 |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | CADL | $7.99 | -2.4% | 189.01K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Candel Therapeutics, Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW